ARCHIVES

Chronobiology Review Still Delayed

This article is from The Cancer Letter archive.

Vol. 15 No. 18 | May 5, 1989

Download PDF Visit The Full Archive

Related Articles

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

November 29, 2013

ASCO Ends Early Distribution Of Abstracts To Halt “ASCO Effect” On Stock Market

January 24, 2003

Gallo, Rosenberg, Bishop, Varmus Win GM Awards

June 15, 1984

Hormone Therapy Can Reduce Survival In Men With Heart Problems

August 26, 2011

FDA Committee Approves Two NDAs, Blocks One, Hears NCI Toxicology Plan

June 15, 1979

Biotheraputices To Reveal Plans for Expansion

August 8, 1986